Literature DB >> 20411441

Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Tobias D Merson1, Michele D Binder, Trevor J Kilpatrick.   

Abstract

As the resident innate immune cells of the central nervous system (CNS), microglia fulfil a critical role in maintaining tissue homeostasis and in directing and eliciting molecular responses to CNS damage. The human disease Multiple Sclerosis and animal models of inflammatory demyelination are characterized by a complex interplay between degenerative and regenerative processes, many of which are regulated and mediated by microglia. Cellular communication between microglia and other neural and immune cells is controlled to a large extent by the activity of cytokines. Here we review the role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination, highlighting their importance in potentiating cell damage, promoting neuroprotection and enhancing cellular repair in a context-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411441     DOI: 10.1007/s12017-010-8112-z

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  441 in total

1.  Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells.

Authors:  A M Healy; J J Schwartz; X Zhu; B E Herrick; B Varnum; H W Farber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

Review 2.  Toll-like receptor signaling.

Authors:  Shizuo Akira
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

3.  Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations.

Authors:  Yoshifumi Sonobe; Izumi Yawata; Jun Kawanokuchi; Hideyuki Takeuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  Brain Res       Date:  2005-04-08       Impact factor: 3.252

4.  c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.

Authors:  Vicki Waetzig; Karen Czeloth; Ute Hidding; Kirsten Mielke; Moritz Kanzow; Stephan Brecht; Mario Goetz; Ralph Lucius; Thomas Herdegen; Uwe-Karsten Hanisch
Journal:  Glia       Date:  2005-05       Impact factor: 7.452

5.  Production of hemopoietic colony-stimulating factors by astrocytes.

Authors:  U V Malipiero; K Frei; A Fontana
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

6.  Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

Authors:  L D Johns; K C Flanders; G E Ranges; S Sriram
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

7.  Interleukin-6 expression in human multiple sclerosis lesions.

Authors:  L M Schönrock; G Gawlowski; W Brück
Journal:  Neurosci Lett       Date:  2000-11-10       Impact factor: 3.046

8.  Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination.

Authors:  Jeffrey L Mason; Shouhong Xuan; Ioannis Dragatsis; Argiris Efstratiadis; James E Goldman
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

9.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

10.  Interleukin-6 is elevated in plasma in multiple sclerosis.

Authors:  K Frei; S Fredrikson; A Fontana; H Link
Journal:  J Neuroimmunol       Date:  1991-02       Impact factor: 3.478

View more
  34 in total

Review 1.  Injury and repair in the neurovascular unit.

Authors:  Changhong Xing; Kazuhide Hayakawa; Josephine Lok; Ken Arai; Eng H Lo
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

3.  Neochlorogenic Acid Inhibits Lipopolysaccharide-Induced Activation and Pro-inflammatory Responses in BV2 Microglial Cells.

Authors:  Mina Kim; Sang-Yoon Choi; Pyeongjae Lee; Jinyoung Hur
Journal:  Neurochem Res       Date:  2015-07-08       Impact factor: 3.996

4.  Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.

Authors:  Mahmoud L Soliman; Colin K Combs; Thad A Rosenberger
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-12       Impact factor: 4.147

Review 5.  Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.

Authors:  Debora Giunti; Benedetta Parodi; Christian Cordano; Antonio Uccelli; Nicole Kerlero de Rosbo
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

6.  Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.

Authors:  Alex K Ray; Juwen C DuBois; Ross C Gruber; Hillary M Guzik; Maria E Gulinello; Geoffrey Perumal; Cedric Raine; Lauren Kozakiewicz; Julie Williamson; Bridget Shafit-Zagardo
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

Review 7.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

Review 8.  Do not judge a cell by its cover--diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.

Authors:  Stefanie M Brendecke; Marco Prinz
Journal:  Semin Immunopathol       Date:  2015-08-07       Impact factor: 9.623

Review 9.  New immunological approaches in treating and diagnosing CNS diseases.

Authors:  Kathy Guo; Damir Janigro
Journal:  Pharm Pat Anal       Date:  2013-05

10.  Myelin antigen load influences antigen presentation and severity of central nervous system autoimmunity.

Authors:  Ritika Jaini; Daniela C Popescu; Chris A Flask; Wendy B Macklin; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2013-04-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.